| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:PPARδ agonist 8
CAS:2697129-55-6
Package:25mg/RMB 10600;100mg/RMB 17500;50mg/RMB 13800
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Email: |
info@biorbyt.com |
| Products Intro: |
Product Name:PPARδ agonist 8
CAS:2697129-55-6
|
Propanoic acid, 2-[4-[3-hydroxy-3-(2-methoxy-3-quinolinyl)propyl]-2,6-dimethylphenoxy]-2-methyl- manufacturers
- PPARδ agonist 8
-
- $1520.00 / 25mg
-
2025-07-19
- CAS:2697129-55-6
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Propanoic acid, 2-[4-[3-hydroxy-3-(2-methoxy-3-quinolinyl)propyl]-2,6-dimethylphenoxy]-2-methyl- Basic information |
| | Propanoic acid, 2-[4-[3-hydroxy-3-(2-methoxy-3-quinolinyl)propyl]-2,6-dimethylphenoxy]-2-methyl- Chemical Properties |
| Boiling point | 606.6±55.0 °C(Predicted) | | density | 1.210±0.06 g/cm3(Predicted) | | pka | 3.39±0.11(Predicted) |
| | Propanoic acid, 2-[4-[3-hydroxy-3-(2-methoxy-3-quinolinyl)propyl]-2,6-dimethylphenoxy]-2-methyl- Usage And Synthesis |
| Uses | Pparδ agonist 8 is a potent agonist of Pparδ. The peroxisome proliferator-activated receptor (PPAR) is a member of the intranuclear receptor transcription factor superfamily that plays a key role in the regulation of metabolic homeostasis, inflammation, cell growth and differentiation in vivo. Pparδ agonist 8 has the potential for the research of non-alcoholic fatty liver disease (NAFLD) (extracted from patent WO2021169769A1, compound TM2)[1]. | | References | [1] Shoujun Chen, et al. Aromatic compounds and pharmaceutical compositions and uses thereof. Patent WO2021169769A1. |
| | Propanoic acid, 2-[4-[3-hydroxy-3-(2-methoxy-3-quinolinyl)propyl]-2,6-dimethylphenoxy]-2-methyl- Preparation Products And Raw materials |
|